Global Intracardiac Imaging Market Growth (Status and Outlook) 2023-2029
There has been a significant process in the file of coronary imaging in the past decade. The non-fluoroscopic intracardiac imaging is increasingly used to guide interventional electrophysiology therapeutic procedures. This is primarily due to the advantage of real-time, direct observation and improved procedure guidance that the intracardiac imaging devices offer over the fluoroscopy methods.
LPI (LP Information)' newest research report, the “Intracardiac Imaging Industry Forecast” looks at past sales and reviews total world Intracardiac Imaging sales in 2022, providing a comprehensive analysis by region and market sector of projected Intracardiac Imaging sales for 2023 through 2029. With Intracardiac Imaging sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Intracardiac Imaging industry.
This Insight Report provides a comprehensive analysis of the global Intracardiac Imaging landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Intracardiac Imaging portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Intracardiac Imaging market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Intracardiac Imaging and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Intracardiac Imaging.
The global Intracardiac Imaging market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Intracardiac Imaging is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Intracardiac Imaging is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Intracardiac Imaging is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Intracardiac Imaging players cover Boston Scientific, GE, Siemens, ACIST Medical Systems, InfraReDx, Avinger and Abbott, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Intracardiac Imaging market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
Intracardiac Echo Imaging
Transthoracic Echo Imaging
Others
Segmentation by application
Hospitals
Diagnostics Imaging Centers
Ambulatory Surgical Centers
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Boston Scientific
GE
Siemens
ACIST Medical Systems
InfraReDx
Avinger
Abbott
Please note: The report will take approximately 2 business days to prepare and deliver.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook